Provided by Tiger Trade Technology Pte. Ltd.

CHINARES PHARMA

4.610
-0.060-1.28%
Volume:9.70M
Turnover:44.75M
Market Cap:28.96B
PE:8.69
High:4.670
Open:4.650
Low:4.590
Close:4.670
52wk High:5.668
52wk Low:4.350
Shares:6.28B
HK Float Shares:6.28B
Volume Ratio:0.89
T/O Rate:0.15%
Dividend:0.14
Dividend Rate:3.05%
EPS(LYR):0.530
ROE:7.57%
ROA:2.66%
PB:0.51
PE(LYR):8.69
PS:0.10

Loading ...

China Resources Pharmaceutical (3320) and Dong-E-E-Jiao (000423) Announce Health Consumer Products Industrial Park Investment

Bulletin Express
·
Feb 10

Dong-E-E-Jiao Co.,Ltd., a CHINARES PHARMA Subsidiary, Plans Health Consumer Goods Industrial Park

Stock News
·
Feb 10

China Resources Pharmaceutical investiert rund 1,4 Milliarden RMB in neues Gesundheitsindustriepark-Projekt

Reuters
·
Feb 10

China Resources Pharmaceutical Group Ltd - Investment in and Construction of Health Consumer Products Industrial Park

THOMSON REUTERS
·
Feb 10

BRIEF-China Resources Pharmaceutical Announces Potential Disposal Of Tianmai Biotechnology

Reuters
·
Feb 09

China Resources Pharmaceutical (3320) Announces Potential Disposal of Tianmai Biotechnology

Bulletin Express
·
Feb 09

CHINARES PHARMA Considers Divesting Approximately 17.87% Stake in Tianmai Biotech

Stock News
·
Feb 09

China Resources Pharmaceutical Group Seeks to Sell 17.87% Stake in Tianmai Biotechnology

Reuters
·
Feb 09

China Resources Pharmaceutical - Disposal Through Public Tender Process on Shanghai United Assets and Equity Exchange

THOMSON REUTERS
·
Feb 09

China Resources Pharmaceutical - Unit Initiated Potential Disposal of 17.87% Stake in Hefei Tianmai Biotechnology Development

THOMSON REUTERS
·
Feb 09

China Resources Pharmaceutical Group Ltd - a Minimum Listing Price of Approximately RMB1.42 Bln

THOMSON REUTERS
·
Feb 09

China Resources Pharmaceutical Group Ltd - Potential Disposal of Tianmai Biotechnology

THOMSON REUTERS
·
Feb 09

Tasly Pharmaceutical's Profit Rises 16% in 2025

MT Newswires Live
·
Feb 09

CR Pharmaceutical Group (3320) Announces Approval of EGM Resolutions

Bulletin Express
·
Feb 06

China Resources Pharmaceutical Group Ltd. hielt außerordentliche Hauptversammlung ab

Reuters
·
Feb 06

BRIEF-China Resources Pharmaceutical Updates On KPC Pharmaceuticals

Reuters
·
Feb 06

KPC Pharmaceutical's 2025 Profit Slips 46%

MT Newswires Live
·
Feb 06

Tasly Pharmaceutical Reports 11.05 Billion Yuan Net Profit for 2025, Marking 15.68% Year-on-Year Growth

Stock News
·
Feb 06

CR Pharmaceutical (3320) Announces CR Sanjiu’s 2025 Preliminary Financial Results

Bulletin Express
·
Feb 06

CR Sanjiu Posts 14.53% Revenue Growth Under China Resources Pharmaceutical Group

Reuters
·
Feb 06